查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1755859

2032 年免疫測量市場預測：按產品類型、平台、技術、檢體類型、應用、最終用戶和地區進行的全球分析

Immunoassay Market Forecasts to 2032 - Global Analysis By Product Type (Reagents & Kits, Analyzers, Software & Services, and Other Product Types), Platform, Technology, Specimen Type, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球免疫測量市場預計在 2025 年達到 407.4 億美元，到 2032 年將達到 693.8 億美元，預測期內的複合年成長率為 7.9%。

免疫測量是一種利用抗原抗體反應來測量液體樣本中某種物質的存在或濃度的生化檢測方法。免疫測定廣泛應用於診斷、藥物研究和環境檢測，以檢測荷爾蒙、藥物、蛋白質和病原體。免疫測量具有較高的敏感度和特異性，使其成為疾病診斷、治療藥物監測和生物醫學研究應用的重要工具。

根據國發會預估，2025年台灣老齡人口比將達19.9%，2030年將達23.9%，2035年將達27.3%。

慢性病增多

癌症、心血管疾病和自體免疫疾病等慢性疾病的增加推動了免疫測量檢測的需求。免疫測量在疾病診斷、監測和治療管理中發揮至關重要的作用，並廣泛應用於臨床。此外，檢測技術的進步提高了靈敏度和特異性，增強了其在診斷實驗室中的應用。人口老化和感染疾病病率的上升進一步促進了市場擴張。

設備和試劑高成本

先進的檢測系統需要高昂的前期投資，這阻礙了中小型醫療保健機構採用這些技術。試劑和耗材的經常性支出推高了整體營運成本，並限制了其可近性，尤其是在新興經濟體。此外，嚴格的監管標準要求昂貴的驗證流程，這增加了製造商的財務負擔。成本限制也阻礙了自動化免疫測量設備在資源有限的醫療保健機構中的廣泛應用。

POC 偵測需求

POC免疫測量系統能夠快速且準確地診斷疾病，從而促進及時的醫療干預。由於其便捷高效，POC檢測在醫院、診所和家庭醫療保健機構的應用日益廣泛。可攜式免疫測量設備的技術進步提高了其可近性，尤其是在偏遠和服務不足的地區。人們對疾病早期檢測意識的不斷提高，進一步推動了POC免疫測量測定儀器的需求。市場參與企業正在投資技術創新，以開發方便用戶使用且經濟高效的POC檢測解決方案。

標準化有限

檢測表現的差異會導致診斷結果的差異，並影響臨床決策。實驗室和醫療保健機構在整合不同製造商的免疫測量系統時，面臨互通性問題。缺乏普遍接受的測量方案使品管變得複雜，並引發了對檢測可靠性的擔憂。儘管監管機構強調標準化，但不同技術之間的協調仍然難以實現。

COVID-19的影響

由於對快速且準確的診斷檢測需求的迫切，COVID-19 疫情極大地推動了免疫測量市場的發展。用於檢測和監測病毒的抗體和抗原檢測需求激增，刺激了技術創新和產能提升。各國政府和醫療機構在診斷領域投入巨資，擴大了市場規模，並加快了監管核准。疫情過後，人們對感染疾病的認知不斷提高，並為未來的疫情爆發做好了準備，這推動了免疫測量領域的持續成長和技術進步。

試劑和套件部分預計將成為預測期內最大的部分

由於試劑和套件盒在免疫測量測定檢測程序中發揮關鍵作用，預計將在預測期內佔據最大的市場佔有率。醫院、診斷實驗室和研究機構的高試劑消耗率促成了該細分市場的巨大佔有率。全球診斷檢測數量的增加推動了對免疫測量測定試劑的需求。試劑配方的不斷改進提高了檢測靈敏度，從而促進了其廣泛應用。

預測期內，醫院和診所部門的複合年成長率最高

由於患者人數不斷增加且診斷需求不斷成長，預計醫院和診所細分市場將在預測期內實現最高成長率。免疫測量方法在醫院廣泛用於疾病篩檢、治療監測和緊急診斷。醫院實驗室正在採用自動化免疫測量分析儀，以提高效率和準確性。醫療保健投資的不斷成長以及對高通量檢測解決方案的需求正在推動市場擴張。

最大佔有率區域：

在預測期內，由於醫療保健行業的快速發展，預計亞太地區將佔據最大的市場佔有率。政府對醫療基礎設施的持續投資，推動了中國、印度和日本等主要國家的市場成長。人們對疾病早期診斷和預防意識的不斷提高，推動了免疫測量方法的採用。感染疾病和慢性病的盛行率上升，也加速了先進診斷解決方案的需求。

複合年成長率最高的地區：

由於擁有先進的醫療基礎設施和強力的法律規範，預計北美地區在預測期內的複合年成長率最高。大型診斷公司和研究機構的存在正在加速免疫測量技術的創新。醫療支出的增加和政府對精準醫療的支持措施正在推動市場擴張。慢性病負擔的加重以及對早期診斷解決方案的需求正在推動免疫測量的普及。

免費客製化服務：

訂閱此報告的客戶將獲得以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球免疫測量市場（依產品類型）

  • 試劑和套件
    • ELISA套件
    • 快速檢測套組
    • 蛋白質印跡試劑套件
    • PCR試劑套件
  • 分析儀
    • 開放式系統
    • 封閉式系統
  • 軟體和服務
    • 資料管理軟體
    • 維護服務
    • 檢驗和客製化服務
  • 其他產品類型

6. 全球免疫測量市場（依平台）

  • 基於實驗室
  • 照護現場檢驗 (POC)

7. 全球免疫測量市場（依技術）

  • 酵素免疫測量（ELISA）
  • 化學冷光免疫測量（CLIA）
  • 螢光免疫測量（FIA）
  • 免疫測量（RIA）
  • 橫向流動化驗
  • 其他技術

8. 全球免疫測量市場（依檢體類型）

  • 血
  • 尿
  • 唾液
  • 其他檢體

第9章全球免疫測量市場（按應用）

  • 感染疾病
  • 治療藥物監測
  • 腫瘤學
  • 自體免疫疾病
  • 心臟病學
  • 內分泌學
  • 其他用途

第 10 章。全球免疫測量市場（按最終用戶分類）

  • 醫院和診所
  • 診斷實驗室
  • 學術研究所
  • 製藥和生物技術公司
  • 血庫
  • 居家照護環境
  • 其他最終用戶

第 11 章。按地區分類的全球免疫測量市場

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司概況

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • bioMerieux SA
  • DiaSorin SpA
  • Becton, Dickinson and Company（BD）
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • QuidelOrtho Corporation
  • PerkinElmer Inc.
  • QIAGEN NV
  • Merck KGaA
  • Fujirebio, Inc.
Product Code: SMRC29753

According to Stratistics MRC, the Global Immunoassay Market is accounted for $40.74 billion in 2025 and is expected to reach $69.38 billion by 2032 growing at a CAGR of 7.9% during the forecast period. An immunoassay is a biochemical test that measures the presence or concentration of a substance, typically in a liquid sample, using the reaction between an antigen and an antibody. It is widely used in diagnostics, pharmaceutical research, and environmental testing to detect hormones, drugs, proteins, or pathogens. Immunoassays offer high sensitivity and specificity, making them essential tools in disease diagnosis, therapeutic drug monitoring, and biomedical research applications.

According to the National Development Council, the geriatric population of Taiwan will reach 19.9% in 2025, 23.9% in 2030, and 27.3% in 2035.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and autoimmune conditions is driving demand for immunoassay testing. Immunoassays play a crucial role in disease diagnosis, monitoring, and treatment management, leading to their widespread adoption in clinical settings. Additionally, advancements in assay technologies have improved sensitivity and specificity, enhancing their application in diagnostic laboratories. The aging population and rising incidence of infectious diseases further contribute to market expansion.

Restraint:

High cost of instruments and reagents

High initial investment requirements for advanced assay systems deter small and medium healthcare providers from adopting these technologies. The recurring expenses of reagents and consumables add to the overall operational cost, limiting accessibility, particularly in developing economies. Additionally, stringent regulatory standards necessitate expensive validation processes, increasing financial burden on manufacturers. Cost constraints also hinder widespread adoption of automated immunoassay analyzers in resource-limited healthcare settings.

Opportunity:

Point-of-Care testing demand

POC immunoassay systems enable rapid and accurate disease diagnosis, facilitating timely medical intervention. The convenience and efficiency of POC testing are driving adoption across hospitals, clinics, and home healthcare settings. Technological advancements in portable immunoassay devices are enhancing accessibility, especially in remote and underserved regions. Rising awareness regarding early disease detection is further boosting demand for POC immunoassays. Market participants are investing in innovation to develop user-friendly and cost-effective POC testing solutions.

Threat:

Limited standardization

Variability in assay performance can lead to inconsistencies in diagnostic results, affecting clinical decision-making. Laboratories and healthcare providers struggle with interoperability issues when integrating immunoassay systems from different manufacturers. The absence of universally accepted assay protocols complicates quality control efforts, raising concerns about test reliability. Regulatory bodies emphasize standardization, but achieving harmonization across diverse technologies remains complex.

Covid-19 Impact

The COVID-19 pandemic significantly boosted the immunoassay market due to the urgent need for rapid and accurate diagnostic testing. Demand surged for antibody and antigen tests to detect and monitor the virus, driving innovation and increased production capacity. Governments and healthcare organizations invested heavily in diagnostics, expanding market size and accelerating regulatory approvals. Post-pandemic, the heightened awareness of infectious diseases and preparedness for future outbreaks continue to sustain growth and technological advancement in the immunoassay sector.

The reagents & kits segment is expected to be the largest during the forecast period

The reagents & kits segment is expected to account for the largest market share during the forecast period, due to its critical role in immunoassay testing procedures. High consumption rates of reagents in hospitals, diagnostic laboratories, and research institutions contribute to its significant market share. The rising number of diagnostic tests globally is increasing the demand for immunoassay reagents. Continuous advancements in reagent formulations are improving assay sensitivity, fuelling their widespread adoption.

The hospitals & clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals & clinics segment is predicted to witness the highest growth rate, driven by increasing patient volumes and diagnostic needs. Immunoassays are widely used in hospitals for disease screening, therapeutic monitoring, and emergency diagnostics. The integration of automated immunoassay analyzers in hospital laboratories is improving efficiency and accuracy. Rising healthcare investments and the demand for high-throughput testing solutions are propelling market expansion.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its rapidly expanding healthcare sector. Increasing government investments in medical infrastructure are fuelling market growth across key countries such as China, India, and Japan. Rising awareness regarding early disease diagnosis and prevention is driving immunoassay adoption. The growing prevalence of infectious and chronic diseases is accelerating demand for advanced diagnostic solutions.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its advanced healthcare infrastructure and strong regulatory framework. The presence of leading diagnostic companies and research institutions accelerates innovation in immunoassay technologies. Increasing healthcare expenditure and government initiatives supporting precision medicine are driving market expansion. The rising burden of chronic diseases and demand for early diagnostic solutions are fuelling immunoassay adoption.

Key players in the market

Some of the key players profiled in the Immunoassay Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific Inc., bioMerieux SA, DiaSorin S.p.A., Becton, Dickinson and Company (BD), Sysmex Corporation, Bio-Rad Laboratories, Inc., QuidelOrtho Corporation, PerkinElmer Inc., QIAGEN N.V., Merck KGaA, and Fujirebio, Inc.

Key Developments:

In February 2025, Abbott and Shedd Aquarium are announcing one of Shedd's largest corporate gifts in recent history - a $10 million pledge from Abbott and Abbott's philanthropic foundation, Abbott Fund. The investment cements the longstanding partnership between Shedd, Abbott, and Abbott Fund to enrich the cultural, educational and environmental fabric of Chicago and spark passion for protecting the ocean environment.

In July 2024, Siemens Healthineers, a leading medical technology company, announced that the Multix Impact E digital radiography X-ray machine will now be manufactured in India, marking a significant milestone in the company's commitment to providing better access to care for patients in the country.

Product Types Covered:

  • Reagents & Kits
  • Analyzers
  • Software & Services
  • Other Product Types

Platforms Covered:

  • Laboratory-Based
  • Point-of-Care (POC) Testing

Technologies Covered:

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Chemiluminescence Immunoassays (CLIA)
  • Fluorescence Immunoassays (FIA)
  • Radioimmunoassay (RIA)
  • Lateral Flow Assays
  • Others Technologies

Specimen Types Covered:

  • Blood
  • Urine
  • Saliva
  • Other Specimens

Applications Covered:

  • Infectious Diseases
  • Therapeutic Drug Monitoring
  • Oncology
  • Autoimmune Diseases
  • Cardiology
  • Endocrinology
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Blood Banks
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Immunoassay Market, By Product Type

  • 5.1 Introduction
  • 5.2 Reagents & Kits
    • 5.2.1 ELISA Kits
    • 5.2.2 Rapid Test Kits
    • 5.2.3 Western Blot Kits
    • 5.2.4 PCR-based Kits
  • 5.3 Analyzers
    • 5.3.1 Open-Ended Systems
    • 5.3.2 Closed-Ended Systems
  • 5.4 Software & Services
    • 5.4.1 Data Management Software
    • 5.4.2 Maintenance Services
    • 5.4.3 Validation & Custom Services
  • 5.5 Other Product Types

6 Global Immunoassay Market, By Platform

  • 6.1 Introduction
  • 6.2 Laboratory-Based
  • 6.3 Point-of-Care (POC) Testing

7 Global Immunoassay Market, By Technology

  • 7.1 Introduction
  • 7.2 Enzyme-Linked Immunosorbent Assay (ELISA)
  • 7.3 Chemiluminescence Immunoassays (CLIA)
  • 7.4 Fluorescence Immunoassays (FIA)
  • 7.5 Radioimmunoassay (RIA)
  • 7.6 Lateral Flow Assays
  • 7.7 Others Technologies

8 Global Immunoassay Market, By Specimen Type

  • 8.1 Introduction
  • 8.2 Blood
  • 8.3 Urine
  • 8.4 Saliva
  • 8.5 Other Specimens

9 Global Immunoassay Market, By Application

  • 9.1 Introduction
  • 9.2 Infectious Diseases
  • 9.3 Therapeutic Drug Monitoring
  • 9.4 Oncology
  • 9.5 Autoimmune Diseases
  • 9.6 Cardiology
  • 9.7 Endocrinology
  • 9.8 Other Applications

10 Global Immunoassay Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Clinics
  • 10.3 Diagnostic Laboratories
  • 10.4 Academic & Research Institutes
  • 10.5 Pharmaceutical & Biotechnology Companies
  • 10.6 Blood Banks
  • 10.7 Home Care Settings
  • 10.8 Other End Users

11 Global Immunoassay Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Abbott Laboratories
  • 13.2 F. Hoffmann-La Roche Ltd.
  • 13.3 Siemens Healthineers
  • 13.4 Danaher Corporation
  • 13.5 Thermo Fisher Scientific Inc.
  • 13.6 bioMerieux SA
  • 13.7 DiaSorin S.p.A.
  • 13.8 Becton, Dickinson and Company (BD)
  • 13.9 Sysmex Corporation
  • 13.10 Bio-Rad Laboratories, Inc.
  • 13.11 QuidelOrtho Corporation
  • 13.12 PerkinElmer Inc.
  • 13.13 QIAGEN N.V.
  • 13.14 Merck KGaA
  • 13.15 Fujirebio, Inc.

List of Tables

  • Table 1 Global Immunoassay Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Immunoassay Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Immunoassay Market Outlook, By Reagents & Kits (2024-2032) ($MN)
  • Table 4 Global Immunoassay Market Outlook, By ELISA Kits (2024-2032) ($MN)
  • Table 5 Global Immunoassay Market Outlook, By Rapid Test Kits (2024-2032) ($MN)
  • Table 6 Global Immunoassay Market Outlook, By Western Blot Kits (2024-2032) ($MN)
  • Table 7 Global Immunoassay Market Outlook, By PCR-based Kits (2024-2032) ($MN)
  • Table 8 Global Immunoassay Market Outlook, By Analyzers (2024-2032) ($MN)
  • Table 9 Global Immunoassay Market Outlook, By Open-Ended Systems (2024-2032) ($MN)
  • Table 10 Global Immunoassay Market Outlook, By Closed-Ended Systems (2024-2032) ($MN)
  • Table 11 Global Immunoassay Market Outlook, By Software & Services (2024-2032) ($MN)
  • Table 12 Global Immunoassay Market Outlook, By Data Management Software (2024-2032) ($MN)
  • Table 13 Global Immunoassay Market Outlook, By Maintenance Services (2024-2032) ($MN)
  • Table 14 Global Immunoassay Market Outlook, By Validation & Custom Services (2024-2032) ($MN)
  • Table 15 Global Immunoassay Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 16 Global Immunoassay Market Outlook, By Platform (2024-2032) ($MN)
  • Table 17 Global Immunoassay Market Outlook, By Laboratory-Based (2024-2032) ($MN)
  • Table 18 Global Immunoassay Market Outlook, By Point-of-Care (POC) Testing (2024-2032) ($MN)
  • Table 19 Global Immunoassay Market Outlook, By Technology (2024-2032) ($MN)
  • Table 20 Global Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2024-2032) ($MN)
  • Table 21 Global Immunoassay Market Outlook, By Chemiluminescence Immunoassays (CLIA) (2024-2032) ($MN)
  • Table 22 Global Immunoassay Market Outlook, By Fluorescence Immunoassays (FIA) (2024-2032) ($MN)
  • Table 23 Global Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2024-2032) ($MN)
  • Table 24 Global Immunoassay Market Outlook, By Lateral Flow Assays (2024-2032) ($MN)
  • Table 25 Global Immunoassay Market Outlook, By Others Technologies (2024-2032) ($MN)
  • Table 26 Global Immunoassay Market Outlook, By Specimen Type (2024-2032) ($MN)
  • Table 27 Global Immunoassay Market Outlook, By Blood (2024-2032) ($MN)
  • Table 28 Global Immunoassay Market Outlook, By Urine (2024-2032) ($MN)
  • Table 29 Global Immunoassay Market Outlook, By Saliva (2024-2032) ($MN)
  • Table 30 Global Immunoassay Market Outlook, By Other Specimens (2024-2032) ($MN)
  • Table 31 Global Immunoassay Market Outlook, By Application (2024-2032) ($MN)
  • Table 32 Global Immunoassay Market Outlook, By Infectious Diseases (2024-2032) ($MN)
  • Table 33 Global Immunoassay Market Outlook, By Therapeutic Drug Monitoring (2024-2032) ($MN)
  • Table 34 Global Immunoassay Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 35 Global Immunoassay Market Outlook, By Autoimmune Diseases (2024-2032) ($MN)
  • Table 36 Global Immunoassay Market Outlook, By Cardiology (2024-2032) ($MN)
  • Table 37 Global Immunoassay Market Outlook, By Endocrinology (2024-2032) ($MN)
  • Table 38 Global Immunoassay Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 39 Global Immunoassay Market Outlook, By End User (2024-2032) ($MN)
  • Table 40 Global Immunoassay Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 41 Global Immunoassay Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 42 Global Immunoassay Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 43 Global Immunoassay Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 44 Global Immunoassay Market Outlook, By Blood Banks (2024-2032) ($MN)
  • Table 45 Global Immunoassay Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 46 Global Immunoassay Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.